Verloren negatively regulates the expression of IMD pathway dependent antimicrobial peptides in Drosophila

Prakash, P., Roychowdhury Sinha, A. and Goto, A. (2021) Verloren negatively regulates the expression of IMD pathway dependent antimicrobial peptides in Drosophila. Scientific Reports, 11, 15549. (doi: 10.1038/s41598-021-94973-0) (PMID:34330981) (PMCID:PMC8324896)

[img] Text
320484.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Abstract

Drosophila immune deficiency (IMD) pathway is similar to the human tumor necrosis factor receptor (TNFR) signaling pathway and is preferentially activated by Gram-negative bacterial infection. Recent studies highlighted the importance of IMD pathway regulation as it is tightly controlled by numbers of negative regulators at multiple levels. Here, we report a new negative regulator of the IMD pathway, Verloren (Velo). Silencing of Velo led to constitutive expression of the IMD pathway dependent antimicrobial peptides (AMPs), and Escherichia coli stimulation further enhanced the AMP expression. Epistatic analysis indicated that Velo knock-down mediated AMP upregulation is dependent on the canonical members of the IMD pathway. The immune fluorescent study using overexpression constructs revealed that Velo resides both in the nucleus and cytoplasm, but the majority (~ 75%) is localized in the nucleus. We also observed from in vivo analysis that Velo knock-down flies exhibit significant upregulation of the AMP expression and reduced bacterial load. Survival experiments showed that Velo knock-down flies have a short lifespan and are susceptible to the infection of pathogenic Gram-negative bacteria, P. aeruginosa. Taken together, these data suggest that Velo is an additional new negative regulator of the IMD pathway, possibly acting in both the nucleus and cytoplasm.

Item Type:Articles
Additional Information:This work was supported by the National Institutes of Health (PO1 AI070167), the Balzan Foundation (to J.A.H.), the Investissement d’Avenir Programs (ANR-11-EQPX-0022), the Sino-French Hoffmann Institute, LIA (Laboratoire international associé) «REL2 and resistance to malaria», USIAS (University of Strasbourg Institute for Advanced Study), CNRS, and INSERM.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Roychowdhury Sinha, Dr Arghyashree
Authors: Prakash, P., Roychowdhury Sinha, A., and Goto, A.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Scientific Reports
Publisher:Nature Research
ISSN:2045-2322
ISSN (Online):2045-2322
Copyright Holders:Copyright © The Author(s) 2021
First Published:First published in Scientific Reports 11:15549
Publisher Policy:Reproduced under a creative commons licence

University Staff: Request a correction | Enlighten Editors: Update this record